(Q36750252)

16 August 2017

0 references

1 reference

title

Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation (English)

1 reference

16 August 2017

1 reference

1

Guohua Xia

1 reference

16 August 2017

7

Joseph R Calabrese

1 reference

16 August 2017

6

Stephen J Ganocy

1 reference

16 August 2017

3

David J Muzina

1 reference

16 August 2017

Prashant Gajwani

2

1 reference

16 August 2017

David E Kemp

series ordinal

4

1 reference

16 August 2017

Keming Gao

series ordinal

5

1 reference

16 August 2017

5 March 2007

1 reference

The International Journal of Neuropsychopharmacology

16 August 2017

1 reference

16 August 2017

11

1 reference

16 August 2017

1

1 reference

16 August 2017

119-130

1 reference

Previous mood state predicts response and switch rates in patients with bipolar depression

16 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A case report of repetitive transcranial magnetic stimulation-induced mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Screening for bipolar disorder in the community

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Bipolar depression: issues in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Treatment emergent affective switch: a controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Mania after transcranial magnetic stimulation in PTSD.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Typical and atypical antipsychotics in bipolar depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Induction of mania by rTMS: report of two cases

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Switch to mania after slow rTMS of the right prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Transcranial magnetic stimulation-induced switch into mania: a report of two cases.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Maintenance therapies in bipolar disorder: focus on randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Pharmacotherapy of depression and mixed states in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Mood state at study entry as predictor of the polarity of relapse in bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007699

7 January 2021

10.1017/S1461145707007699

Identifiers

DOI

0 references

1 reference